HEMISPHERE ENERGY CORP (HME.CA) Fundamental Analysis & Valuation
TSX-V:HME • CA4236301020
Current stock price
2.96 CAD
+0.12 (+4.23%)
Last:
This HME.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HME.CA Profitability Analysis
1.1 Basic Checks
- HME had positive earnings in the past year.
- HME had a positive operating cash flow in the past year.
- Each year in the past 5 years HME has been profitable.
- In the past 5 years HME always reported a positive cash flow from operatings.
1.2 Ratios
- HME's Return On Assets of 23.12% is amongst the best of the industry. HME outperforms 98.03% of its industry peers.
- With an excellent Return On Equity value of 34.75%, HME belongs to the best of the industry, outperforming 98.52% of the companies in the same industry.
- HME's Return On Invested Capital of 29.46% is amongst the best of the industry. HME outperforms 99.01% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for HME is significantly above the industry average of 6.97%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 23.12% | ||
| ROE | 34.75% | ||
| ROIC | 29.46% |
ROA(3y)26.51%
ROA(5y)23.13%
ROE(3y)39.59%
ROE(5y)36.39%
ROIC(3y)32.46%
ROIC(5y)33.96%
1.3 Margins
- The Profit Margin of HME (29.84%) is better than 94.58% of its industry peers.
- HME's Profit Margin has improved in the last couple of years.
- With an excellent Operating Margin value of 42.20%, HME belongs to the best of the industry, outperforming 92.61% of the companies in the same industry.
- In the last couple of years the Operating Margin of HME has grown nicely.
- HME has a better Gross Margin (60.69%) than 77.83% of its industry peers.
- In the last couple of years the Gross Margin of HME has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.2% | ||
| PM (TTM) | 29.84% | ||
| GM | 60.69% |
OM growth 3Y-2.15%
OM growth 5Y14.92%
PM growth 3Y10.62%
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y1.06%
2. HME.CA Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HME is creating value.
- Compared to 1 year ago, HME has less shares outstanding
- Compared to 5 years ago, HME has more shares outstanding
- The debt/assets ratio for HME has been reduced compared to a year ago.
2.2 Solvency
- HME has an Altman-Z score of 6.21. This indicates that HME is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of HME (6.21) is better than 85.22% of its industry peers.
- The Debt to FCF ratio of HME is 0.09, which is an excellent value as it means it would take HME, only 0.09 years of fcf income to pay off all of its debts.
- HME has a Debt to FCF ratio of 0.09. This is amongst the best in the industry. HME outperforms 96.55% of its industry peers.
- A Debt/Equity ratio of 0.03 indicates that HME is not too dependend on debt financing.
- HME's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. HME outperforms 76.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.09 | ||
| Altman-Z | 6.21 |
ROIC/WACC3.67
WACC8.03%
2.3 Liquidity
- A Current Ratio of 1.37 indicates that HME should not have too much problems paying its short term obligations.
- The Current ratio of HME (1.37) is better than 69.46% of its industry peers.
- A Quick Ratio of 1.37 indicates that HME should not have too much problems paying its short term obligations.
- With a decent Quick ratio value of 1.37, HME is doing good in the industry, outperforming 70.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 |
3. HME.CA Growth Analysis
3.1 Past
- The earnings per share for HME have decreased strongly by -15.15% in the last year.
- The Earnings Per Share has been growing by 10.83% on average over the past years. This is quite good.
- HME shows a decrease in Revenue. In the last year, the revenue decreased by -6.07%.
- The Revenue has been growing by 38.14% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-15.15%
EPS 3Y10.83%
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)-6.07%
Revenue growth 3Y-0.99%
Revenue growth 5Y38.14%
Sales Q2Q%-18.71%
3.2 Future
- Based on estimates for the next years, HME will show a very negative growth in Earnings Per Share. The EPS will decrease by -16.11% on average per year.
- HME is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.33% yearly.
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. HME.CA Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 10.57 indicates a reasonable valuation of HME.
- 75.37% of the companies in the same industry are more expensive than HME, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 26.91. HME is valued rather cheaply when compared to this.
- A Price/Forward Earnings ratio of 11.50 indicates a reasonable valuation of HME.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of HME indicates a somewhat cheap valuation: HME is cheaper than 74.38% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 21.99. HME is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.57 | ||
| Fwd PE | 11.5 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, HME is valued cheaply inside the industry as 90.64% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of HME indicates a rather cheap valuation: HME is cheaper than 90.64% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.75 | ||
| EV/EBITDA | 5 |
4.3 Compensation for Growth
- HME has an outstanding profitability rating, which may justify a higher PE ratio.
- A cheap valuation may be justified as HME's earnings are expected to decrease with -16.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
5. HME.CA Dividend Analysis
5.1 Amount
- HME has a Yearly Dividend Yield of 3.50%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 3.03, HME pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.82, HME pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
5.2 History
- HME has been paying a dividend for over 5 years, so it has already some track record.
- HME has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
- 54.76% of the earnings are spent on dividend by HME. This is a bit on the high side, but may be sustainable.
DP54.76%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
HME.CA Fundamentals: All Metrics, Ratios and Statistics
TSX-V:HME (4/28/2026, 7:00:00 PM)
2.96
+0.12 (+4.23%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Industry Strength84.25
Industry Growth44.78
Earnings (Last)04-15 2026-04-15/bmo
Earnings (Next)05-20 2026-05-20
Inst Owners0.94%
Inst Owner ChangeN/A
Ins Owners10.46%
Ins Owner ChangeN/A
Market Cap279.13M
Revenue(TTM)93.86M
Net Income(TTM)28.01M
Analysts84.44
Price Target2.96 (0%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP54.76%
Div Incr Years0
Div Non Decr Years3
Ex-Date05-14 2026-05-14 (0.03)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11%
Min EPS beat(2)-19.09%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-5.53%
Min EPS beat(4)-19.09%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.2%
EPS beat(12)4
Avg EPS beat(12)-3.78%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.09%
Min Revenue beat(2)-3.98%
Max Revenue beat(2)-0.21%
Revenue beat(4)2
Avg Revenue beat(4)1.55%
Min Revenue beat(4)-3.98%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)1.46%
Revenue beat(12)7
Avg Revenue beat(12)0.74%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.73%
PT rev (3m)19.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-9.09%
EPS NY rev (3m)-3.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.03%
Revenue NY rev (1m)-3.26%
Revenue NY rev (3m)-7.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.57 | ||
| Fwd PE | 11.5 | ||
| P/S | 2.97 | ||
| P/FCF | 8.75 | ||
| P/OCF | 5.8 | ||
| P/B | 3.46 | ||
| P/tB | 3.46 | ||
| EV/EBITDA | 5 |
EPS(TTM)0.28
EY9.46%
EPS(NY)0.26
Fwd EY8.7%
FCF(TTM)0.34
FCFY11.43%
OCF(TTM)0.51
OCFY17.25%
SpS1
BVpS0.85
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.32039 (-21.61%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 23.12% | ||
| ROE | 34.75% | ||
| ROCE | 39.28% | ||
| ROIC | 29.46% | ||
| ROICexc | 36.52% | ||
| ROICexgc | 36.52% | ||
| OM | 42.2% | ||
| PM (TTM) | 29.84% | ||
| GM | 60.69% | ||
| FCFM | 33.99% |
ROA(3y)26.51%
ROA(5y)23.13%
ROE(3y)39.59%
ROE(5y)36.39%
ROIC(3y)32.46%
ROIC(5y)33.96%
ROICexc(3y)37.5%
ROICexc(5y)37.01%
ROICexgc(3y)37.5%
ROICexgc(5y)37.01%
ROCE(3y)43.29%
ROCE(5y)45.29%
ROICexgc growth 3Y-7.82%
ROICexgc growth 5Y43.82%
ROICexc growth 3Y-7.82%
ROICexc growth 5Y43.82%
OM growth 3Y-2.15%
OM growth 5Y14.92%
PM growth 3Y10.62%
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y1.06%
F-Score6
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.09 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 140.25% | ||
| Cap/Sales | 17.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 94.07% | ||
| Profit Quality | 113.94% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 6.21 |
F-Score6
WACC8.03%
ROIC/WACC3.67
Cap/Depr(3y)180.21%
Cap/Depr(5y)207.89%
Cap/Sales(3y)19.72%
Cap/Sales(5y)21.17%
Profit Quality(3y)100.55%
Profit Quality(5y)107.06%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.15%
EPS 3Y10.83%
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.07%
Revenue growth 3Y-0.99%
Revenue growth 5Y38.14%
Sales Q2Q%-18.71%
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A
EBIT growth 1Y-11.49%
EBIT growth 3Y-3.12%
EBIT growth 5Y58.75%
EBIT Next Year28.61%
EBIT Next 3Y-3.62%
EBIT Next 5YN/A
FCF growth 1Y29.21%
FCF growth 3Y5.96%
FCF growth 5Y32.87%
OCF growth 1Y3.47%
OCF growth 3Y2.22%
OCF growth 5Y38.68%
HEMISPHERE ENERGY CORP / HME.CA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?
ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.
What is the valuation status for HME stock?
ChartMill assigns a valuation rating of 7 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.
What is the profitability of HME stock?
HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.
Can you provide the financial health for HME stock?
The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 8 / 10.
What is the earnings growth outlook for HEMISPHERE ENERGY CORP?
The Earnings per Share (EPS) of HEMISPHERE ENERGY CORP (HME.CA) is expected to decline by -8.04% in the next year.